Methylation of the prominin 1 TATA-less main promoters and tissue specificity of their transcript content

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1779, Issue 10, 2008, Pages 599-605

  Pleshkan, Victor V ^a   Vinogradova, Tatyana V ^a   Sverdlov, Eugene D ^a  

^a SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

Author keywords

Alternative promoter; CD133; Methylation; Regulation of gene expression; Transcriptional isoform

Indexed keywords

GLYCOPROTEIN; PROMININ 1; PROMININ 2; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL LINE; EXON; HUMAN; HUMAN CELL; METHYLATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TISSUE SPECIFICITY;

ALTERNATIVE SPLICING; ANTIGENS, CD; CELLS, CULTURED; DNA METHYLATION; GLYCOPROTEINS; HELA CELLS; HUMANS; JURKAT CELLS; ORGAN SPECIFICITY; PEPTIDES; PROMOTER REGIONS, GENETIC; PROTEIN ISOFORMS; RNA, MESSENGER; TATA BOX; TISSUE DISTRIBUTION; TRANSCRIPTION INITIATION SITE;

EID: 52049124277     PISSN: 18749399     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2008.06.002     Document Type: Article

References (21)

1. Fargeas C.A., Corbeil D., and Huttner W.B. AC133 antigen, CD133, prominin-1, prominin-2, etc.: prominin family gene products in need of a rational nomenclature. Stem Cells. 21 (2003) 506-508
2. Weigmann A., Corbeil D., Hellwig A., and Huttner W.B. Prominin, a novel microvilli-specific polytopic membrane protein of the apical surface of epithelial cells, is targeted to plasmalemmal protrusions of non-epithelial cells. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 12425-12430
3. Miraglia S., Godfrey W., Yin A.H., Atkins K., Warnke R., Holden J.T., Bray R.A., Waller E.K., and Buck D.W. A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 90 (1997) 5013-5021
4. Bhatia M. AC133 expression in human stem cells. Leukemia 15 (2001) 1685-1688
5. Corbeil D., Roper K., Fargeas C.A., Joester A., and Huttner W.B. Prominin: a story of cholesterol, plasma membrane protrusions and human pathology. Traffic 2 (2001) 82-91
6. Yin A.H., Miraglia S., Zanjani E.D., Almeida-Porada G., Ogawa M., Leary A.G., Olweus J., Kearney J., and Buck D.W. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 90 (1997) 5002-5012
7. Uchida N., Buck D.W., He D., Reitsma M.J., Masek M., Phan T.V., Tsukamoto A.S., Gage F.H., and Weissman I.L. Direct isolation of human central nervous system stem cells. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 14720-14725
8. Katoh Y., and Katoh M. Comparative genomics on PROM1 gene encoding stem cell marker CD133. Int. J. Mol. Med. 19 (2007) 967-970
9. Shmelkov S.V., Jun L., St Clair R., McGarrigle D., Derderian C.A., Usenko J.K., Costa C., Zhang F., Guo X., and Rafii S. Alternative promoters regulate transcription of the gene that encodes stem cell surface protein AC133. Blood 103 (2004) 2055-2061
10. Corbeil D., Roper K., Hellwig A., Tavian M., Miraglia S., Watt S.M., Simmons P.J., Peault B., Buck D.W., and Huttner W.B. The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions. J. Biol. Chem. 275 (2000) 5512-5520
11. Peichev M., Naiyer A.J., Pereira D., Zhu Z., Lane W.J., Williams M., Oz M.C., Hicklin D.J., Witte L., Moore M.A., and Rafii S. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 95 (2000) 952-958
12. Richardson G.D., Robson C.N., Lang S.H., Neal D.E., Maitland N.J., and Collins A.T. CD133, a novel marker for human prostatic epithelial stem cells. J. Cell. Sci. 117 (2004) 3539-3545
13. Torrente Y., Belicchi M., Sampaolesi M., Pisati F., Meregalli M., D'Antona G., Tonlorenzi R., Porretti L., Gavina M., Mamchaoui K., Pellegrino M.A., Furling D., Mouly V., Butler-Browne G.S., Bottinelli R., Cossu G., and Bresolin N. Human circulating AC133(+) stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle. J. Clin. Invest. 114 (2004) 182-195
14. Maw M.A., Corbeil D., Koch J., Hellwig A., Wilson-Wheeler J.C., Bridges R.J., Kumaramanickavel G., John S., Nancarrow D., Roper K., Weigmann A., Huttner W.B., and Denton M.J. A frameshift mutation in prominin (mouse)-like 1 causes human retinal degeneration. Hum. Mol. Genet. 9 (2000) 27-34
15. Yu Y., Flint A., Dvorin E.L., and Bischoff J. AC133-2, a novel isoform of human AC133 stem cell antigen. J. Biol. Chem. 277 (2002) 20711-20716
16. Fargeas C.A., Huttner W.B., and Corbeil D. Nomenclature of prominin-1 (CD133) splice variants - an update. Tissue Antigens 69 (2007) 602-606
17. Fargeas C.A., Joester A., Missol-Kolka E., Hellwig A., Huttner W.B., and Corbeil D. Identification of novel prominin-1/CD133 splice variants with alternative C-termini and their expression in epididymis and testis. J. Cell. Sci. 117 (2004) 4301-4311
18. Chakraborty A.K., Funasaka Y., Slominski A., Ermak G., Hwang J., Pawelek J.M., and Ichihashi M. Production and release of proopiomelanocortin (POMC) derived peptides by human melanocytes and keratinocytes in culture: regulation by ultraviolet. B. Biochim. Biophys. Acta. 1313 (1996) 130-138
19. Elkahloun A.G., Bittner M., Hoskins K., Gemmill R., and Meltzer P.S. Molecular cytogenetic characterization and physical mapping of 12q13-15 amplification in human cancers. Genes Chromosomes Cancer 17 (1996) 205-214
20. Olek A., Oswald J., and Walter J. A modified and improved method for bisulphite based cytosine methylation analysis. Nucleic. Acids Res. 24 (1996) 5064-5066
21. Majka M., Ratajczak J., Machalinski B., Carter A., Pizzini D., Wasik M.A., Gewirtz A.M., and Ratajczak M.Z. Expression, regulation and function of AC133, a putative cell surface marker of primitive human haematopoietic cells. Folia Histochem. Cytobiol. 38 (2000) 53-63